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Abstract The formation of appropriate connections be-
tween neurons and their specific targets is an essential step
during development and repair of the nervous system.
Growth cones are located at the leading edges of the growing
neurites and respond to environmental cues in order to be
guided to their final targets. Directional information can be
coded by concentration gradients of substrate-bound or
diffusible-guidance molecules. Here we show that concen-
tration gradients of adenosine stimulate growth cones of
sensory neurons (dorsal root ganglia) from chicken embryos
to turn towards the adenosine source. This response is
mediated by adenosine receptors. The subsequent signal
transduction process involves cAMP. It may be speculated
that the in vivo function of this response is concerned with
the formation or the repair and regeneration of the peripheral
nervous system.
Keywords Growthcone.Guidance.DRG.Gradient.
cAMP.Adenosinereceptor
Introduction
Many guidance molecules not only control the growth
direction, but also affect neurite initiation and elongation
[1]. Purins are interesting in this respect as it has been
shown that they are capable of promoting neurite growth
[2–5] and that micro-gradients of ATP induce growth-cone
turning of embryonic neurons from Xenopus [6]. Here we
investigate a possible involvement of adenosine in growth-
cone turning of neurons, a new function for this molecule.
An example that adenosine may have new, so far unknown,
cell biological functions has been recently given by Chen
and colleagues [7], who showed that adenosine regulates
migration speed of neutrophil cells during chemotaxis.
Effects of extracellular adenosine are mediated by
receptors belonging to the super family of G protein-coupled
receptors [8], which also include members known to
mediate growth-cone turning [9, 10]. The family of
adenosine receptors comprises four subtypes, A1,A 2A,
A2B, and A3 [11], linked to a variety of downstream
signalling pathways, both cAMP dependent and indepen-
dent [12, 13]. Whereas the activation of A1 or A3 receptors
decreases the intracellular cAMP concentration by inhibi-
tion of the adenylate cyclase, A2A and A2B receptor
activation stimulates adenylate cyclase activity and thereby
increases the intracellular cAMP concentration. It is known
that cAMP has an effect on growth-cone turning [14–16],
thus providing a link between adenosine receptors and
growth-cone turning.
In order to induce changes in the growing direction,
guidance cues must provide directional information detect-
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Leuven, Belgiumable by the corresponding receptors. This directional
information can be coded by the shape of a concentration
gradient [17]. It has been shown that concentration
gradients of adenosine exist in the nervous system under
in vivo conditions [18]. Due to the action of ectonucleoti-
dases [19], each cell that releases ATP can be assumed to be
the centre of an adenosine gradient. Moreover, cellular
release of adenosine has also been shown [20, 21].
Here we use sensory neurons from chicken dorsal root
ganglia (DRG), a system that has been used by others in
growth-cone-turning assays [14, 22–25] to investigate the
effect of adenosine on growth-cone turning. We show that
micro-gradients of adenosine (ADO) generated by a micro-
pipette technique are capable of inducing a positive growth-
cone turning response. The present data demonstrate that
the turning response is adenosine receptor mediated, as it
emanates from experiments with the unspecific adenosine
receptor agonist NECA and the unspecific adenosine receptor
antagonist CGS 15943. Further studies with the A2A selective
adenosine receptor agonist CGS 21680 confirm this finding
and, apart from that, indicate that A2A receptor activation can
induce a positive turning response. In contrast to this we
found no effect on growth-cone turning when the A1 receptor
agonist R-(-)-PIA was used. The precise nature of the
adenosine receptor(s) involved in mediating the adenosine-
induced turning response will require further study. The role
of cAMP during adenosine-receptor-induced growth-cone
turning seems to be elusive. While the cAMP antagonist Rp-
cAMPS or KT 5720, which is a protein kinase A (PKA)
inhibitor, block growth-cone turning in ADO gradients, the
turning in CGS 21680 gradients is not affected by KT 5720,
whereas Rp-cAMPS is effective and blocks CGS 21680-
induced turning.
Materials and methods
Cell culture and experimental procedures
Glass-bottom dishes were used for cell culture and turning
experiments. To achieve optimum growth conditions, the
bottom was first coated overnight with 0.1 mg/ml poly-D-
lysine. Finally, the dishes were coated with 0.25 μg/ml
laminin (Hoffmann-La Roche, Basel, Switzerland) for 1 h
at 37°C. DRGs were dissected from 11-day-old chicken
embryos and cultivated without dissociation overnight. The
cell culture medium consisted of 90% DMEM F12 with
HEPES (Invitrogen, Karlsruhe, Germany), 10% FCS (Invi-
trogen, Karlsruhe, Germany), 100 μg/ml streptomycin, 100
units/ml penicillin and was supplemented with 25 ng/ml 7 S
NGF (Becton Dickinson, Franklin Lakes, NJ, USA)
[26, 27]. Mineral oil [mouse embryo tested, light oil (neat),
Sigma, St. Louis, MO, USA] was used during the turning
experiments to cover the cell culture medium in order to
avoid outgassing and evaporation. The whole setup used to
measure growth-cone turning was heated to 37°C. Special
care was taken to avoid temperature differences in the cell
culture dish during the measurement to circumvent distur-
bance of the concentration gradients due to convection.
Antagonists were added to the bath solution 30 min before
the start of the experiment and were also present in the
pipette solution.
Generation of micro-gradients
Micro-pipettes were made from borosilicate glass capillary
tubes (outer diameter 1.6 mm; wall thickness 0.336 mm;
Hilgendberg, Malsfeld, Germany) using an electrode puller
(DMZ Universal Puller, Zeitz Instruments, Munich,
Germany). The pulling programs were optimised to produce
pipettes with either 80–100 or 40–60 MΩ resistance
corresponding to an inner tip diameter of 1 or 3 μm,
respectively. All pipette solutions were filtered through a
0.2μmmembranefiltertoavoidcloggingthepipetteopening.
The pipette solution was ejected by the constant hydrostatic
pressure of a 35 mm water column. Micro-pipettes were
inserted through the mineral oil layer into the cell culture dish
with the help of a micro-manipulator. By rotating the cell
culture dish, the angle between the pipette and longitudinal
axis of the investigated neurite was adjusted to 90°. The
pipette tip was positioned at a distance of 50 μmf r o mt h e
growth cone and at a 45° angle with respect to the direction of
neurite extension.
Characterisation of micro-gradients
The shapes of the micro-gradients were characterised by
using micro-pipettes that were filled with a 1 mM solution
of 5-(and-6)-carboxyfluorescein (mixed isomers). Growth-
cone turning is induced by concentration differences near
the surface of the culture substrate where the growth cones
adhere. Therefore gradients were characterised by total
internal reflection fluorescence (TIRF) measurements that
limit the investigated layer in the z-direction to the
evanescent field depth [28]. This corresponds to the space
where gradient detection by the growth cone takes place.
Measurements were performed using an inverted epifluor-
escence microscope (Axiovert 200, Zeiss, Jena, Germany)
equipped with a 100× oil immersion objective (α Plan
Fluar 100×/1.45 oil/∞/0.17, Zeiss, Jena, Germany), a CDD
camera (IMAGO-SVGA), a TIRF condensor (TILL-TIRF
module), and a 488 nm laser (Sapphire 488–20, Coherent,
Santa Clara, CA, USA). The TIRF measurements were
calibrated by normalising the background-corrected images
of the gradients with an image, in which the chamber was
filled with the undiluted pipette solution.
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carboxyfluorescein measurements is a reasonable estimate
for the gradients in the growth-cone-turning experiments, as
diffusion coefficients of carboxyfluorescein and the inves-
tigated compounds (mainly adenosine) are comparable.
This is suggested by two lines of evidence. The diffusion
coefficient can be calculated on the basis of the Stokes-
Einstein radius [29], which is related to molecular weight
and molecular volume. Both values are in the same range
for adenosine (molecular weight: 267.24; molecular vol-
ume: 128.1 cm
3/mol) and carboxyfluoresceine (molecular
weight:332.3;molecularvolume:207.4cm
3/mol) [30]. Further
evidence comes from literature: while Rani et al. [31]g i v ea
diffusion coefficient for fluoresceine of 4.9×10
–6 cm
2 s
-1
(21.5°C in water), Mohrman [32] concludes that the diffusion
coefficient of adenosine is similar to that of sucrose, which is
5.1×10
–6 cm
2 s
-1.
Optical setup
An inverted epifluorescence microscope (IX70-S1F, Olym-
pus, Tokyo, Japan) equipped with a 40× oil immersion
objective (UAPO 40× OL/340/1.35, Olympus, Tokyo, Japan)
was used throughout the study except for the TIRF measure-
ments.ThesetupwasequippedwithaCCDcamera(IMAGO-
VGA) for time-lapse microscopy and was controlled by
TILLvisIon (version 4.0), which was also used for image
analysis. All imaging equipment was supplied by TILL
Photonics (Gräfelfing, Germany) unless otherwise noted.
Measurement of extension and turning of growth cones
Neurite growth was analysed according to Ming et al. [33]
including the modifications of Munck et al. [14]. In short,
the growth direction before the onset of the stimulus was
aligned with the y-axis of a coordinate system. Turning
angles were determined by measuring the angles between
the ordinate and a straight line connecting the origin of the
coordinate system (starting point of the growth cone) with
the final growth-cone position. Positive angles were defined
to be on the right side of the ordinate (stimulated side) and
negative angles to be on the left side. Data were statistically
analysed using the Mann-Whitney U test. Deviations are
given as standard error of the mean (SEM). All growth-
cone-turning experiments lasted 15 min. Neurites that
retracted during this period were not included in further
analysis.
Chemicals
The following chemicals were used in growth-cone-turning
assays: ADO, NECA, CGS 21680, CGS 15943, R-(-)-PIA,
KT 5720 (Calbiochem-Novabiochem, San Diego, CA,
USA), and Rp-cAMPS (Biomol, Hamburg, Germany).
Stock solutions of these chemicals were prepared in
dimethyl sulfoxide (DMSO), with the exception of the
water soluble Rp-cAMPS. If not stated otherwise, chem-
icals were bought from Sigma (St. Louis, MO, USA).
Results
Cultures of DRG sensory neurons from embryonic chickens
have been used by various groups to investigate different
aspects of growth-cone turning [14, 22–25, 34, 35]. Herein
explant cultures of chicken (E 11) DRGs were used to
investigate a possible effect of ADO on the direction of
growth-cone advance. During time-lapse image recordings
of elongating neurites, the growth cones were exposed to
extracellular gradients of ADO and related compounds. The
effect of these concentration gradients on growth direction
was analysed on the basis of growth tracks that were
extracted by image analysis from the images of the time-
lapse recordings (cf. “Materials and methods”).
Generation and characterisation of micro-gradients
Constraints for effective guidance with soluble compounds
are that the concentration falls between certain maximum
and minimum limits, and that the percentage change in
concentration across the width of the growth cone exceeds
a certain minimum value [36]. Therefore, we characterised
the pipettes and the respective gradients produced with it.
Here extracellular concentration gradients were generated
by gravity-driven flow of the respective compound (or
vehicle control) from a micro-pipette. Two pipette types
were compared, as the gradient shape and gradient
evolution depend on the geometry of the pipette. The inner
tip diameter was analysed with raster electron microscopy
and for the small pipette type was typically 1 µm and for
the larger type 3 µm (Fig. 1). The gradients generated with
these pipettes were investigated by TIRF-microscopic
measurements as described in “Materials and methods”.
These experiments show that the gradients stabilise within
5 min and stay stable for the duration of the experiments,
and that the gradient properties depend on pipette geometry.
Using the small pipette filled with a 1 mM solution of
carboxyfluorescein, the dye concentration decreased from
about 1 μM at a distance of 5 μm to 0.6 μM at a point
50 μm distant from the pipette. The corresponding data for
the large pipette were 17 μMa t5μm to 1.5 μMa t5 0μm
(Fig. 1). Similar diffusion coefficients of carboxyfluores-
cein and ADO allowed the estimation of the ADO
concentrations at different distances from the pipette tip
on the basis of the carboxyfluorescein data. These estima-
tions resulted in ADO concentrations of 100 nM at a
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the pipette tip for small pipettes filled with 100 μM ADO.
For the large pipette, the values at the corresponding
positions and pipette solution were 1.7 μM and 150 nM.
Possible ADO content of the cell culture medium is not
included in those values.
Growth-cone turning in ADO gradients
In standard experiments, the distance between growth cone
and pipette tip was 50 μm at the start. Neurites from control
cells elongated at a mean speed of 76±5.2 μm/h (SEM).
With respect to these constraints, we limited the measuring
period to 15 min to guarantee a minimum distance between
growth cone and pipette tip throughout the experiment. The
turning behaviour of populations of growth cones in the
presence of micro-gradients of ADO or vehicle controls is
shown in Fig. 2 by superimposing traces of individual
trajectories of neurite extension. A 1-μm pipette filled with
100 μM ADO consistently induced a chemotrophic turning
response toward the pipette over the investigated time
period of 15 min. Statistical analysis revealed that this
ADO-induced turning response is significant compared to a
vehicle control. Contrary to this finding, we did not observe
a significant turning response using a 3-μm pipette filled
with 100 μM ADO (Fig. 2). This result can be explained by
the fact that growth-cone turning happens only if the
gradient shape satisfies certain cellular conditions [36].
To examine whether growth-cone attraction by an ADO
source is mediated by adenosine receptors, the unspecific
adenosine receptor agonist NECA [11] was used. This
agonist has a higher affinity to the different ADO receptors
than ADO itself [37, 38]. Therefore we reduced the pipette
concentration of NECA by a factor of ten relative to the
ADO concentration. The rationale behind this approach is
that growth cones can detect a concentration gradient only
if the respective receptors are not saturated with the ligand
[17]. This experiment resulted in a significant turning of
growth cones towards the pipette filled with 10 μM NECA.
Data are shown together with the results of other ADO
receptor agonists and antagonists in Fig. 3. The turning
response towards a pipette filled with 100 µM ADO could
be blocked by using the unspecific ADO receptor antago-
nist CGS 15943 [39]. This antagonist was added both to the
bath solution and to the pipette solution in a concentration
of 10 μM.
The experiments with unspecific ADO receptor agonists
and antagonists indicated that the ADO-induced growth-
cone turning is transduced by ADO receptors. As the A2B
and the A3 receptors have only a low affinity to ADO (KD
5,100 and 6,500 nM respectively [38]), a significant
participation of these receptors in growth-cone-turning
experiments seems implausible as the ADO concentration
in this experiments was less than 100 nM. From this point
of view the A1 and A2A receptors seem to be better
candidates, as the binding constants of these receptors are
70 nM (A1) and 150 nM (A2A)[ 38].
Therefore, we tested the effect of R-(-)-PIA, an A1
receptor specific agonist [37]. Addition of 2 µM to the
pipette solution was ineffective in inducing growth-cone
Fig. 2a–e Adenosine induces positive turning of growth cones. Image
of a growth cone from a chick sensory neuron a before and b 15 min
after insertion of a 1-μm pipette filled with 100 μM ADO. c, d
Trajectories of neurites grown for 15 min in a gradient. The pipette
solution contained either c 100 μM ADO or d 10 μl/ml DMSO for the
control. The trajectories were aligned in such a way that growth cones
started from the origin and grew in direction of the ordinate. The ADO
gradient is visualised schematically. e Cumulative distribution of
turning angles of the growth cones exposed to gradients produced by a
1-μm pipette filled with either control solution (diamonds) or 100 μM
ADO (squares) and a 3-μm pipette filled with 100 μM ADO
(triangles). Values at the ordinate refer to the percentage of neurites
with a turning angle inferior or equal to the angle given at the
abscissa. Under experimental conditions which induce growth-cone
attraction, the curve is shifted to the right
Fig. 1a–c Relation between pipette geometry and gradient shape. a, b
Scanning electron microscopic images of the two compared pipette
types. Scale bar in a and b 1 μm. c Line plot of the concentration
gradients generated by the respective pipette type (upper line 3 μm
pipette, lower line 1 μm pipette). The plot was extracted from images
of a TIRF measurement, as described in the “Materials and methods”
section. Measuring parameters were as follows: pipette solution:
1 mM carboxyfluorescein; pressure: 35 mm water column; time:
5 min after inserting the pipette
360 Purinergic Signalling (2008) 4:357–364turning (data not shown). As the absence of a turning
response can always be caused by inappropriate gradient
shape, we tested whether a concentration increase to 10 μM
in the stimulating pipette has any effect (Fig. 3). However,
this condition was as ineffective as a decreased start
distance (35 μm instead of 50 μm) between growth cone
and a micro-pipette containing 2 μM R-(-)-PIA (data not
shown). In summary, we have no indication that a growth-
cone turning response can be activated by R-(-)-PIA. In
contrast to this, a pipette filled with 10 μM of the A2A
receptor specific agonist CGS 21680 [40] induced a
significant attractant response.
These results provide additional evidence that the
observed turning response is mediated by adenosine
receptors. Moreover, the results suggest that A2A receptor
activation is involved in adenosine-induced growth-cone
turning of chicken sensory neurons.
First investigations on the signal transduction chain
of ADO-induced growth-cone turning
It is well known that cAMP is an important downstream
signal transducer of adenosine receptors [13]. Therefore, we
tested the effect of the cAMP antagonist Rp-cAMPS [41]
on adenosine-induced growth-cone turning. This membrane
permeable antagonist was added in a concentration of
20 μM (data not shown) or 100 μM to the bath and pipette
solution. Under these conditions the attractant response
towards a pipette that contained 100 μM of ADO, in
addition to the antagonist, was inhibited. Rp-cAMPS also
blocked the attractant response towards a pipette filled with
the specific A2A receptor agonist CGS 21680. In these
experiments, the pipette contained 10 μM CGS 21680 and
Rp-cAMPS was added to the bath and to the pipette
solution in a concentration of 100 μM. Together these data
suggest a contribution of cAMP to the signal transduction
chain of adenosine-receptor-induced growth-cone turning
(Fig. 4).
Different downstream effectors of cAMP are known
[42]. One important member of this group is PKA, which
can be blocked by the specific inhibitor KT 5720 [43]. Here
we tested the effect of KT 5720 on adenosine-receptor-
mediated growth-cone turning. KT 5720 was added to bath
and pipette solution in a concentration of 10 μM. Under
these experimental conditions growth-cone turning towards
a pipette that contained 100 μM of ADO was blocked
significantly. However, under the same experimental con-
ditions, KT 5720 failed to block the attractant response of a
pipette filled with 10 μM of the A2A specific agonist CGS
21680 (Fig. 4). These seemingly inconsistent results reveal
the need for a thorough investigation of the signal
transduction chain.
Discussion
The present study demonstrates, for the first time, that
extracellular ADO gradients can guide neuronal processes.
Fig. 4 Effect of cAMP signalling on adenosine-receptor-mediated
growth-cone turning. The cAMP antagonist Rp-cAMPS (100 μM)
inhibits growth-cone turning induced by a 1-μm pipette filled with
ADO (100 μM) or CGS 21680 (10 μM). Whereas the PKA inhibitor
KT 5720 (10 μM) blocked the turning of growth cones in an ADO
gradient, this was not the case when the A2A receptor selective agonist
CGS 21680 was used as a chemoattractant. Displayed are the average
turning angles, error bars indicate standard error of the mean (SEM),
and n the sample size. Significant differences from the control group
are marked (*P<0.05; **P<0.01; Mann-Whitney U test). Antagonists
and inhibitors were added to the culture medium and pipette solution.
Data of the control experiments and the ADO-induced turning have
been taken from Fig. 3
Fig. 3 Effects of different adenosine receptor agonists and antagonists
on growth-cone turning. All experiments were performed with 1-μm
pipettes filled with the respective agonist or 10 μl/ml DMSO for the
control. Both ADO (100 μM) and the unspecific adenosine receptor
agonist NECA (10 μM) induced a significant positive turning
response. In the presence of the unspecific adenosine receptor
antagonist CGS 15943, no ADO-induced turning response was
detectable. CGS 15943 was added to the culture medium and to the
pipette solution in a concentration of 10 μM. The A1 receptor specific
agonist R-(-)-PIA (10 μM) caused no significant turning response. In
contrast to this, a positive turning response was induced by the
specific A2A receptor agonist CGS 21680 (10 μM). Displayed are the
average turning angles, error bars indicate standard error of the mean
(SEM), and n the sample size. Significant differences from the control
group are marked (* P<0.05; ** P<0.01; Mann-Whitney U test)
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nists strongly indicate that the turning reaction is caused by
activation of adenosine receptors. Adenosine receptors
belong to the large family of seven transmembrane G
protein-coupled receptors [8], which contain members
known to be involved in growth-cone turning [9, 10].
The finding that micro-gradients of ADO induce growth-
cone turning is unexpected because of negative results in
comparable experiments [6, 44]. This apparent discrepancy
with our results may be explained by experimental differ-
ences. First of all, the data published so far are derived from
spinal neurons of Xenopus, whereas we investigated sensory
neurons from chicken. Another difference is the concentra-
tion of the agonists used in the studies mentioned above. Fu
and colleagues [6] used a pipette solution containing a 30-
fold higher concentration of ADO than in the present study,
and Stein et al. [44] performed the experiments with a 100-
fold higher concentration of NECA compared to the
concentration in this work. Even though it is hard to
compare micro-gradients used by different labs just on the
basis of published data, we estimate that the agonist
concentrations used in the former studies were significantly
higher than those used in this work, not only in the pipette
solution but also at the site of the growth cones. Our finding
that micro-gradients produced by micro-pipettes with an
increased tip diameter did not attract growth cones supports
the interpretation that high concentrations counteract the
attractive effect of ADO. It is known from the work of
Goodhill [17] that gradient detection is disturbed if the
agonist concentration is high compared to the dissociation
constant for the receptor–ligand complex. In this case almost
all receptors are bound, hence yielding little difference in
binding across the extent of the growth cone. Another reason
for the ineffectiveness of high ADO concentrations might be
that in case of adenosine receptors, one cell can express
several receptor subtypes with different binding constants
and diverse physiological effects. Therefore, at high ADO
concentrations the summed response of different adenosine
receptor subtypes may not favour growth-cone turning.
Homologues to all four known human ADO receptors
have been found in the chicken genome [45–48]. It has
been shown that A1 and A2A receptors are present at
sensory neurons of rodents [49, 50]. We are not aware of
published data showing the presence of ADO receptors on
chicken sensory neurons, but all experiments with agonists
and antagonists shown here indicate that ADO receptors are
present on growth cones of chicken sensory neurons and
are responsible for the observed growth-cone turning
response. The affinities of the different adenosine receptor
subtypes range from an adenosine concentration of ~70 nM
for the A1 receptor up to ~6,500 nM for the A3 receptor
subtype [38, 51]. Here we show that micro-gradients
effective in growth-cone turning have an adenosine con-
centration between 60 and 100 nM. Consequently, the best
candidates for mediating the adenosine response shown
here are the high affinity receptors, namely the A1
(~70 nM) and the A2A (~150 nM) receptor. Experiments
with the subtype-specific adenosine receptor agonist CGS
21680 [40] indicate a function of the A2A receptor in
adenosine-induced growth-cone turning, whereas no re-
sponse was detectable with the usage of the A1 receptor
specific agonist R-(-)-PIA [37]. The latter result argues
against a major contribution of the A1 receptor in the
observed turning response. However, remarkable species
differences have been observed for adenosine receptor
agonists [37], and chicken adenosine receptors are pharma-
cologically not well characterised. Therefore future experi-
ments with ADO receptor subtype-specific ligands have to
clarify whether A2A receptor activation is necessary or
sufficient to induce growth-cone turning in sensory neu-
rons. In particular antagonists (e.g. SCH 58261 [52]) seem
interesting due to the fact that they remove a single player
from the set of different adenosine receptor subtypes that
could be present on the growth cone.
ADO receptor signalling is classically thought to occur
through changing the intracellular cAMP level [53]. Indeed
the presented results show that the cAMP antagonist Rp-
cAMPS blocks growth-cone turning induced by ADO or
the A2A specific agonist CGS 21680. However no clear
picture has emerged by testing a possible involvement of
PKA, an important downstream effector of cAMP. The
PKA-specific inhibitor KT 5720 [43] has different effects,
depending on the used chemoattractant. KT 5720 blocks the
attractant effect of ADO, but not of CGS 21680. One
explanation for this phenomenon could be that ADO and
CGS 21680 activate different subsets of the four known
ADO receptors. As ADO receptors couple to an intricate
network of signalling pathways [54], the activation of
different receptor subsets could be the reason for the
observed difference in sensitivity to KT 5720. Off-target
effects of CGS 21680 to proteins other than ADO receptors
could be an alternative explanation and show the need for
future thorough pharmaceutical characterisation of the
signal transduction chain.
Besides PKA as a target of cAMP, the importance of
‘exchange protein activated by cyclic AMP’ (EPAC) has
also become generally known [55]. It has been shown that
activation of EPAC can promote neurite extension in PC12
cells and that EPAC acts in synergy with PKA during this
process [56]. On this basis one might speculate that EPAC
could also be involved in ADO-induced growth-cone
turning. Our finding that cAMP participates—at least to
some extent—in the signal transduction chain of ADO-
induced growth-cone turning is not unexpected, as exam-
ples of cAMP-dependent growth-cone turning have been
published [10, 14]. On the other hand, a contribution of
362 Purinergic Signalling (2008) 4:357–364cAMP-independent mechanisms cannot be excluded on the
basis of the current data.
The present results show that concentration gradients of
ADO can induce changes in the growth direction of neurons,
raising the question of sources and sinks of extracellular
ADO. Extracellular ADO is either released from cells via
transporters or generated from extracellular adenine nucleo-
tides by the action of ectonucleotidases [19–21]. Not only
ADO sources, but also the mechanisms for removal of
ADO from the extracellular space are diverse and widely
distributed [20, 38]. Therefore, it can be assumed that ADO
concentration gradients that evolve between ADO sources
and sinks are widespread. Direct measurements of such
gradients are rare, but in a report of Chuna [18], evidence
has been provided for an ADO concentration gradient that
surrounds electrically stimulated hippocampal neurons.
At the moment only in vitro data on ADO-induced
growth-cone turning are available, so one can only speculate
on the physiological role and significance of the observed
effect.However,as ADO isknown tohavesignificant effects
in wound healing [57], it might also support the reinervation
of tissue with sensory neurons after lesions.
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